CHD4 and in situ carcinoma: Three interacting antigens, CHD4, GATAD2B, and GATAD2A are members of the nucleosome remodeling and histone deacetylation (NuRD) complex (also called the Mi-2 complex), suggesting that the NuRD complex may be an autoimmune target in CIS/MS.